SUNNYVALE, Calif., Oct. 1, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that it will host an investor meeting on Monday, October 29, 2012 at the annual meeting of the American Society for Radiation Oncology (ASTRO) being held in Boston. The meeting is open to institutional investors and research analysts.
Accuray's management will host a breakfast meeting, from 7:30 a.m. to 9:30 a.m. E.D.T. on Monday, October 29 at the Renaissance Boston Waterfront Hotel, 606 Congress Street Boston, in the Pacific Ballroom, Salon A-C. The presentation will provide a review of Accuray's new technology platforms that will be introduced at ASTRO. Investors who are attending the trade show are encouraged to visit the Accuray booth #7101.
Attendees are asked to register no later than Friday, October 19 from our event website: http://www.cvent.com/d/bcqxrm.
A live webcast of the presentation will be available online from the investor relations section of the company website at www.accuray.com/investors. The webcast replay of the presentation will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days.
About Accuray
Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is the premier radiation oncology company that develops, manufactures and sells personalized, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies – the CyberKnife and TomoTherapy Systems – are designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. To date, 642 systems have been installed in leading hospitals around the world. For more information, please visit www.accuray.com.
Available Topic Expert: For information on the listed expert, click appropriate link.
Euan Thomson, Ph.D.
ProfNet - https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=81869
SOURCE Accuray Incorporated
Investor; Tom Rathjen, Vice President, Investor Relations, +1-408-789-4458, trathjen@accuray.com, OR Media; Stephanie Tomei, Director, Corporate Communications, +1-408-789-4234, stomei@accuray.com
